DSPE-PEG(2000)-Mannose 5 mg | ≥95% Cayman Chemical A PEGylated and mannosylated form of DSPE More Information Supplier Page × DSPE-PEG(2000)-Mannose
DSPE-PEG(2000)-Mannose 10 mg | ≥95% Cayman Chemical A PEGylated and mannosylated form of DSPE More Information Supplier Page × DSPE-PEG(2000)-Mannose
VIRIP (trifluoroacetate salt) 5 mg | ≥95% Cayman Chemical An HIV entry inhibitor and a peptide fragment of alpha-1 antitrypsin More Information Supplier Page × VIRIP (trifluoroacetate salt)
VIRIP (trifluoroacetate salt) 10 mg | ≥95% Cayman Chemical An HIV entry inhibitor and a peptide fragment of alpha-1 antitrypsin More Information Supplier Page × VIRIP (trifluoroacetate salt)
VIRIP (trifluoroacetate salt) 1 mg | ≥95% Cayman Chemical An HIV entry inhibitor and a peptide fragment of alpha-1 antitrypsin More Information Supplier Page × VIRIP (trifluoroacetate salt)
LGD 2226 5 mg | ≥98% Cayman Chemical An androgen receptor agonist More Information Supplier Page × LGD 2226
LGD 2226 25 mg | ≥98% Cayman Chemical An androgen receptor agonist More Information Supplier Page × LGD 2226
LGD 2226 10 mg | ≥98% Cayman Chemical An androgen receptor agonist More Information Supplier Page × LGD 2226
LGD 2226 1 mg | ≥98% Cayman Chemical An androgen receptor agonist More Information Supplier Page × LGD 2226
503O13 5 mg | Purity Not Available Cayman Chemical An ionizable cationic lipidoid More Information Supplier Page × 503O13